Mind Medicine (MindMed) Inc.
MNMD
$12.08
-$0.47-3.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 32.42% | 26.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.65% | 27.19% | |||
| Operating Income | -11.65% | -27.19% | |||
| Income Before Tax | -57.37% | -83.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -57.37% | -83.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -57.37% | -83.07% | |||
| EBIT | -11.65% | -27.19% | |||
| EBITDA | -11.65% | -27.20% | |||
| EPS Basic | -56.39% | -82.44% | |||
| Normalized Basic EPS | -56.39% | -82.51% | |||
| EPS Diluted | -56.39% | -43.74% | |||
| Normalized Diluted EPS | -56.39% | -86.75% | |||
| Average Basic Shares Outstanding | 0.63% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.63% | -2.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||